Omega-3 Fatty Acid

Evidence is “weak” that eating fish can reduce risk for cardiovascular events, and data from multiple large trials suggest fish oil supplementation is CV neutral and may even increase risk for atrial fibrillation, according to a speaker.

The American College of Cardiology recently held its annual meeting. Healio’s coverage of the virtual conference made up the top stories in cardiology last week.

Marine omega-3 fatty acids improved borderline personality disorder symptoms, according to results of a meta-analysis published in Journal of Clinical Psychiatry.

Higher blood levels of eicosapentaenoic acid 1 year after daily omega-3 carboxylic acid supplementation were not associated with lower CV risk, according to a secondary analysis of the STRENGTH trial.

Study findings suggest that omega-3 fatty acid supplementation may increase the risk for atrial fibrillation in certain high-risk patients. This discovery was the top story in cardiology last week.

Omega-3 fatty acid supplementation was associated with elevated risk for atrial fibrillation among patients with elevated triglyceride levels at high CV risk, researchers reported.

Healio Psychiatry has compiled a list of its five most-viewed stories in April.

Among patients with non-ST-segment elevation ACS, a higher relative proportion of plasma long-chain omega-3 polyunsaturated fatty acid was associated with lower chances of sudden cardiac death, researchers reported.

Omega-3 supplementation may slow accelerated aging by altering the body’s response during and after a stressful event, according to study results published in Molecular Psychiatry.

Higher omega-3 fatty acid intake in childhood was associated with lower risk for incident asthma up to mid-adolescence in children with a fatty acid desaturase polymorphism variant, researchers reported in the European Respiratory Journal.